Pfizer ends cholesterol drug development (AP)
AP - Pfizer Inc. said Saturday it has cut off all clinical trials and development for a cholesterol drug that was supposed to be the star of its pipeline because of an unexpected number of deaths and cardiovascular problems in patients who used it.
0 Comments:
Post a Comment
<< Home